Electric vehicle (EV) manufacturer Mullen Automotive (NASDAQ:MULN) has a new majority-owned subsidiary that was formed through a joint venture. Already, Mullen Automotive has made a couple of positive announcements regarding that subsidiary. Therefore, the extreme drawdown in MULN stock looks overdone, and it’s a good time to start a share position in Mullen Automotive. It’s
0 Comments
Electric vehicle (EV) manufacturer Rivian Automotive (NASDAQ:RIVN) has plenty of skeptics. It’s been difficult to defend RIVN stock as it has lost ground in 2023 so far. Unfortunately, the outlook isn’t bright, as Rivian Automotive’s expenditures are disproportionately high. This isn’t to suggest that Rivian Automotive is doing everything wrong. For example, it’s notable that
0 Comments
Energy was the best performing sector the last 2 years. Will it do it again in 2023? Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
0 Comments
In the current polarized geopolitical landscape, there is much apprehension between China and US-led factions. This simmering mistrust has triggered a race for technology and military superiority. Consequently, cyber warfare has emerged as a major frontier for this contest. This article highlights the best cybersecurity stocks to buy as this crisis continues.  Cyber-attacks have intensified
0 Comments
In recent weeks, the Nio (NYSE:NIO) stock slide has continued, following a poorly-received monthly deliveries report Bullish bottom-fishers and dip-buyers may still believe this is prime time to accumulate a position. Mostly, because of their view that the China-based electric vehicle (or EV) maker will experience a strong growth resurgence later this year. As you
0 Comments
With the broader equity indices struggling for traction, rising recession fears brings the glaring spotlight back on so-called real estate bubble stocks. Due to the unique circumstance underlying the Covid-19 crisis and subsequent governmental response, housing prices skyrocketed. In turn, several companies plying their trade in the arena benefitted. But as the saying goes, all
0 Comments
While unproven biotechnology firms almost always carry significant risks, small-cap biotech stocks in particular typically impose jaw-dropping volatility. Along with the usual risk of clinical disappointments or outright failures, these speculative enterprises are obviously less funded. As a result, investors can be taken on a wild ride. Nevertheless, biotech penny stocks – or more generally
0 Comments